Mechanisms of vascular damage in SSc--implications for vascular treatment strategies
Authors:
Open Access
- 10 September 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 47 (Supplement) , v18-v20
Abstract
Vascular abnormalities are a major component of SSc, but little is known about the events or mechanisms that initiate vascular injury and prevent its repair. In SSc, angiogenesis is incomplete or lacking despite the increased expression of a large array of pro-angiogenic factors such as VEGF. Conflicting results have recently been published concerning the presence and role of vasculogenesis and circulating endothelial progenitor cells in SSc. It remains to be established if these endothelial progenitor cells are a marker of endothelial disease or a cause of insufficient vascular repair. Human mesenchymal stem cells (MSCs) may be an alternative source for endothelial progenitor cells, and it has been observed that the angiogenic potential of endothelial-like MSCs is reduced. Other mechanisms of vascular damage include oxidative stress and factors released from activated platelets. In addition, growth factors such as ET-1 and PDGF induce proliferation of vascular smooth muscle cells resulting in intimal thickening. For the development of new therapeutic strategies, it is important to realize that the different vascular pathologies—uncompensated loss of capillaries on one hand and vascular remodelling with a proliferative vasculopathy on the other—might require different treatment approaches.Keywords
This publication has 14 references indexed in Scilit:
- Endothelial progenitor cells and rheumatic disordersJoint Bone Spine, 2008
- Vascular complications of sclerodermaAutoimmunity Reviews, 2007
- Impairment of endothelial cell differentiation from bone marrow–derived mesenchymal stem cells: New insight into the pathogenesis of systemic sclerosisArthritis & Rheumatism, 2007
- How do stem cells find their way home?Blood, 2005
- Matrix metalloproteinase 12–dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesisArthritis & Rheumatism, 2004
- Diverse Contribution of Bone Marrow Cells to Neointimal Hyperplasia After Mechanical Vascular InjuriesCirculation Research, 2003
- Vascular damage and lack of angiogenesis in systemic sclerosis skinClinical Rheumatology, 2003
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Circulating Bone Marrow Cells Can Contribute to Neointimal FormationJournal of Vascular Research, 2001
- Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.Journal of Clinical Investigation, 1996